Zobrazeno 1 - 2
of 2
pro vyhledávání: '"V. S. Shamrai"'
Autor:
V. V. Ptushkin, A. D. Kulagin, E. A. Lukina, I. L. Davydkin, T. S. Konstantinova, V. S. Shamrai, N. V. Minaeva, D. A. Kudlay, E. V. Gapchenko, O. A. Markova, A. Yu. Borozinets
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 77-84 (2020)
Currently, the main pathogenetic method for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) is the treatment with recombinant monoclonal antibodies that block the C5 component of the complement system. Eculizumab is the first biotechnologi
Externí odkaz:
https://doaj.org/article/c8727c8295774e18b3a446395b05b823
Autor:
A. D. Kulagin, O.A. Markova, V S Shamrai, T S Konstantinova, E.V. Gapchenko, N V Minaeva, A Y Borozinets, Elena Lukina, Dmitry Kudlay, I L Davydkin, Vadim V. Ptushkin
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 77-84 (2020)
Currently, the main pathogenetic method for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) is the treatment with recombinant monoclonal antibodies that block the C5 component of the complement system. Eculizumab is the first biotechnologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3830ec32d65d1e091252044c492feb13
https://ter-arkhiv.ru/0040-3660/article/viewFile/43127/pdf
https://ter-arkhiv.ru/0040-3660/article/viewFile/43127/pdf